ADMA Biologics ADMA Plasma Collection Centers — Research And Development Expense

Other segment segments

ADMA Bio Manufacturing

$2.6M+214%

Similar metrics at other companies

HAEPlasma — R&D

$4.94M+15.4%

HAEBlood Center — R&D

$1.03M-26.3%

HAEPlasma products and services — D&A

$11.53M-4.4%

ALMSResearch And Development Prepaid Expenses

$3.35M-74.0%

BCRXResearch, discovery and preclinical programs — Research and Development Expense (Excluding Acquired in Process Cost)

$3.97M+30.4%

TNGXFacilities And Other Related Expenses-RD — Research And Development Expense

$4.34M-20.6%

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's plasma collection centers — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's plasma collection centers — research and development expense?: ADMA Biologics (ADMA) reported plasma collection centers — research and development expense of $0 in Q1 2026.
What does plasma collection centers — research and development expense mean?: Captures expenditures dedicated to improving plasma collection technologies, donor retention processes, or operational efficiencies within the collection centers. While these centers are primarily operational, R&D spending here reflects investment in long-term process innovation. It indicates the company's commitment to optimizing the upstream supply chain.